Europe Ovarian Cancer Market and Competitive Landscape - 2018

  • ID: 4630267
  • Report
  • Region: Europe
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The latest research Europe Ovarian Cancer Market and Competitive Landscape - 2018, provides comprehensive insights into Ovarian Cancer pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Ovarian Cancer market size and drug sales. This research also provides insights into Ovarian Cancer epidemiology and late stage pipeline.

The research is classified into following sections - Ovarian Cancer overview with definitions, symptoms, etiology, diagnosis, treatment options; Ovarian Cancer pipeline insights covering late stage clinical trials pipeline; Ovarian Cancer prevalence trends by countries; Ovarian Cancer market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:
  • Ovarian Cancer pipeline: Find out the drugs in clinical trials for Ovarian Cancer by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Ovarian Cancer epidemiology: Find out the prevalence of Ovarian Cancer by countries - Europe, Germany, France, Italy, Spain, UK; prevalence forecast to 2023
  • Ovarian Cancer products: Identify key products marketed and prescribed for Ovarian Cancer by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK
  • Ovarian Cancer market size: Find out the market size for Ovarian Cancer drugs by countries - Europe, Germany, France, Italy, Spain, UK; Find out how the market advanced from 2014
  • Ovarian Cancer drug sales: Find out the sales of Ovarian Cancer drugs by countries - Europe, Germany, France, Italy, Spain, UK
  • Ovarian Cancer drugs sales forecast: Sales forecast for Ovarian Cancer drugs to 2023 by countries - Europe, Germany, France, Italy, Spain, UK
  • Ovarian Cancer market share analysis: Find out the market shares of Ovarian Cancer drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK
Benefits of this Research:
  • Evaluate commercial market opportunities for Ovarian Cancer drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Ovarian Cancer market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Ovarian Cancer market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Ovarian Cancer: Disease Overview
1.1. Ovarian Cancer Symptoms
1.2. Ovarian Cancer Etiology
1.3. Ovarian Cancer Diagnosis
1.4. Ovarian Cancer Treatment Options

2. Ovarian Cancer Pipeline Insights
2.1. Ovarian Cancer Phase 3 Clinical Trials
2.2. Ovarian Cancer Phase 2 Clinical Trials
2.3. Ovarian Cancer Phase 1 Clinical Trials

3. Ovarian Cancer Epidemiology Analysis

4. Germany Ovarian Cancer Market Insights
4.1. Marketed Products for Ovarian Cancer in Germany
4.2. Germany Ovarian Cancer Market Size & Forecast
4.3. Germany Ovarian Cancer Product Sales Forecast
4.4. Germany Ovarian Cancer Market Share Analysis

5. France Ovarian Cancer Market Insights
5.1. Marketed Products for Ovarian Cancer in France
5.2. France Ovarian Cancer Market Size & Forecast
5.3. France Ovarian Cancer Product Sales Forecast
5.4. France Ovarian Cancer Market Share Analysis

6. Italy Ovarian Cancer Market Insights
6.1. Marketed Products for Ovarian Cancer in Italy
6.2. Italy Ovarian Cancer Market Size & Forecast
6.3. Italy Ovarian Cancer Product Sales Forecast
6.4. Italy Ovarian Cancer Market Share Analysis

7. Spain Ovarian Cancer Market Insights
7.1. Marketed Products for Ovarian Cancer in Spain
7.2. Spain Ovarian Cancer Market Size & Forecast
7.3. Spain Ovarian Cancer Product Sales Forecast
7.4. Spain Ovarian Cancer Market Share Analysis

8. UK Ovarian Cancer Market Insights
8.1. Marketed Products for Ovarian Cancer in UK
8.2. UK Ovarian Cancer Market Size & Forecast
8.3. UK Ovarian Cancer Product Sales Forecast
8.4. UK Ovarian Cancer Market Share Analysis

9. Europe Ovarian Cancer Market Insights
9.1. Europe Ovarian Cancer Market Size & Forecast
9.2. Europe Ovarian Cancer Product Sales Forecast
9.3. Europe Ovarian Cancer Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Ovarian Cancer Phase 3 Clinical Trials, Global, 2018
Table 2: Ovarian Cancer Phase 2 Clinical Trials, Global, 2018
Table 3: Ovarian Cancer Phase 1 Clinical Trials, Global, 2018
Table 4: Ovarian Cancer Prevalence by EU5 Countries, 2014 - 2023
Table 5: Marketed Products for Ovarian Cancer in Germany, 2017
Table 6: Germany Ovarian Cancer Market Size & Forecast ($mn), 2014 - 2023
Table 7: Germany Ovarian Cancer Product Sales ($mn), 2014 - 2023
Table 8: Germany Ovarian Cancer Market Trends, 2014 - 2023
Table 9: Marketed Products for Ovarian Cancer in France, 2017
Table 10: France Ovarian Cancer Market Size & Forecast ($mn), 2014 - 2023
Table 11: France Ovarian Cancer Product Sales ($mn), 2014 - 2023
Table 12: France Ovarian Cancer Market Trends, 2014 - 2023
Table 13: Marketed Products for Ovarian Cancer in Italy, 2017
Table 14: Italy Ovarian Cancer Market Size & Forecast ($mn), 2014 - 2023
Table 15: Italy Ovarian Cancer Product Sales ($mn), 2014 - 2023
Table 16: Italy Ovarian Cancer Market Trends, 2014 - 2023
Table 17: Marketed Products for Ovarian Cancer in Spain, 2017
Table 18: Spain Ovarian Cancer Market Size & Forecast ($mn), 2014 - 2023
Table 19: Spain Ovarian Cancer Product Sales ($mn), 2014 - 2023
Table 20: Spain Ovarian Cancer Market Trends, 2014 - 2023
Table 21: Marketed Products for Ovarian Cancer in UK, 2017
Table 22: UK Ovarian Cancer Market Size & Forecast ($mn), 2014 - 2023
Table 23: UK Ovarian Cancer Product Sales ($mn), 2014 - 2023
Table 24: UK Ovarian Cancer Market Trends, 2014 - 2023
Table 25: Europe Ovarian Cancer Market Size & Forecast ($mn), 2014 - 2023
Table 26: Europe Ovarian Cancer Product Sales ($mn), 2014 - 2023

List of Figures
Figure 1: Ovarian Cancer Pipeline by Phase (%), Global, 2018
Figure 2: Ovarian Cancer Prevalence by EU5 Countries, 2014 - 2023
Figure 3: Germany Ovarian Cancer Market Size ($mn), 2014 - 2023
Figure 4: Germany Ovarian Cancer Product Sales ($mn), 2014 - 2023
Figure 5: Germany Ovarian Cancer Market Share by Products (%), 2017
Figure 6: Germany Ovarian Cancer Market - Future Market Share (%), 2023
Figure 7: France Ovarian Cancer Market Size ($mn), 2014 - 2023
Figure 8: France Ovarian Cancer Product Sales ($mn), 2014 - 2023
Figure 9: France Ovarian Cancer Market Share by Products (%), 2017
Figure 10: France Ovarian Cancer Market - Future Market Share (%), 2023
Figure 11: Italy Ovarian Cancer Market Size ($mn), 2014 - 2023
Figure 12: Italy Ovarian Cancer Product Sales ($mn), 2014 - 2023
Figure 13: Italy Ovarian Cancer Market Share by Products (%), 2017
Figure 14: Italy Ovarian Cancer Market - Future Market Share (%), 2023
Figure 15: Spain Ovarian Cancer Market Size ($mn), 2014 - 2023
Figure 16: Spain Ovarian Cancer Product Sales ($mn), 2014 - 2023
Figure 17: Spain Ovarian Cancer Market Share by Products (%), 2017
Figure 18: Spain Ovarian Cancer Market - Future Market Share (%), 2023
Figure 19: UK Ovarian Cancer Market Size ($mn), 2014 - 2023
Figure 20: UK Ovarian Cancer Product Sales ($mn), 2014 - 2023
Figure 21: UK Ovarian Cancer Market Share by Products (%), 2017
Figure 22: UK Ovarian Cancer Market - Future Market Share (%), 2023
Figure 23: Europe Ovarian Cancer Market Size ($mn), 2014 - 2023
Figure 24: Europe Ovarian Cancer Product Sales ($mn), 2014 - 2023
Figure 25: Europe Ovarian Cancer Market Share by Products (%), 2017
Figure 26: Europe Ovarian Cancer Market - Future Market Share (%), 2023
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll